Does DABRAFENIB Cause Skin lesion? 77 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 77 reports of Skin lesion have been filed in association with DABRAFENIB (Tafinlar). This represents 0.4% of all adverse event reports for DABRAFENIB.
77
Reports of Skin lesion with DABRAFENIB
0.4%
of all DABRAFENIB reports
11
Deaths
27
Hospitalizations
How Dangerous Is Skin lesion From DABRAFENIB?
Of the 77 reports, 11 (14.3%) resulted in death, 27 (35.1%) required hospitalization, and 2 (2.6%) were considered life-threatening.
Is Skin lesion Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DABRAFENIB. However, 77 reports have been filed with the FAERS database.
What Other Side Effects Does DABRAFENIB Cause?
Pyrexia (3,788)
Death (2,740)
Malignant neoplasm progression (1,667)
Fatigue (1,328)
Nausea (1,300)
Chills (1,235)
Rash (1,078)
Vomiting (907)
Diarrhoea (901)
Headache (697)
What Other Drugs Cause Skin lesion?
SECUKINUMAB (1,909)
ADALIMUMAB (1,507)
METHOTREXATE (1,237)
DUPILUMAB (685)
ETANERCEPT (647)
PREDNISONE (617)
TOFACITINIB (478)
INFLIXIMAB (474)
CYCLOSPORINE (380)
LENALIDOMIDE (369)
Which DABRAFENIB Alternatives Have Lower Skin lesion Risk?
DABRAFENIB vs DABRAFENIB\TRAMETINIB
DABRAFENIB vs DACARBAZINE
DABRAFENIB vs DACLATASVIR
DABRAFENIB vs DACLIZUMAB
DABRAFENIB vs DACOMITINIB